My doctor gave me a good lesson in generic manufacturing when I had problems with a dose of a drug that helped diabetes. He said, "Well, we get reports on the generics all the time saying this one or that one has the wrong compound added and we need to tell the customers to take them back."
What?
"They are mostly made in India and China, and they do not always get the formula right. We even had one that added a toxic substance to Valsartan a generic, commonly used angiotensin receptor blockers (ARBs) used for high blood pressure and heart failure to its compound. It isn't often, but more often than we would really like."
The Financial Times has an article on this that shows India far exceeds China in the number of generic approvals (38 for China, 300 for India). There are 900+ generics approved by the Food and Drug Administration. Not getting those formulae right has some concerns when you take them. The next time my diabetes drug doesn't work well, I will remember this, but doing something about it is beyond me.
No comments:
Post a Comment